| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
MMED
MiniMed Group, Inc.
|
Jun 03, 2026 | BUY |
Strong Buy
+48.5% avg upside
13 analysts
|
$20.00
35.48% Upside
|
· |
|
UNCY
Unicycive Therapeutics
|
Jun 02, 2026 | BUY |
Strong Buy
+708.7% avg upside
10 analysts
|
$18.00
162.73% Upside
|
· |
|
HUMA
Humacyte
|
Jun 01, 2026 | BUY |
Strong Buy
+654.7% avg upside
11 analysts
|
$2.00
116.35% Upside
|
-27.2% |
|
BFRI
Biofrontera
|
May 19, 2026 | BUY |
Strong Buy
+507.8% avg upside
2 analysts
|
$3.00
203.86% Upside
|
-1.4% |
|
PODD
Insulet
|
May 12, 2026 | BUY |
Strong Buy
+79.3% avg upside
32 analysts
|
$250.00
71.58% Upside
|
-5.5% |
|
DXCM
Dexcom
|
May 11, 2026 | BUY |
Strong Buy
+38.8% avg upside
32 analysts
|
$77.00
6.18% Upside
|
+23.3% |
|
TNDM
Tandem Diabetes Care
|
May 11, 2026 | HOLD |
Buy
+115.3% avg upside
29 analysts
|
— | +14.4% |
|
NEO
NeoGenomics
|
Apr 29, 2026 | BUY |
Strong Buy
+40.2% avg upside
17 analysts
|
$11.00
1.25% Downside
|
+24.4% |
|
ABT
Abbott Laboratories
|
Apr 17, 2026 | BUY |
Strong Buy
+31.2% avg upside
35 analysts
|
$120.00
35.66% Upside
|
-8.6% |
|
CV
CapsoVision, Inc.
|
Mar 27, 2026 | BUY |
Strong Buy
+36.2% avg upside
3 analysts
|
$10.00
51.34% Upside
|
-14.8% |
|
GNLX
Genelux Corp.
|
Mar 20, 2026 | BUY |
Strong Buy
+513.8% avg upside
7 analysts
|
$20.00
574.54% Upside
|
+26.7% |
|
HBIO
Harvard Bioscience
|
Mar 16, 2026 | BUY |
Strong Buy
+160.0% avg upside
3 analysts
|
$6.00
2.17% Upside
|
+10.2% |
|
BLTE
Belite Bio, Inc. ADR
|
Mar 03, 2026 | BUY |
Strong Buy
+25.0% avg upside
10 analysts
|
$217.00
48.47% Upside
|
-17.7% |
|
CLNN
Clene
|
Dec 03, 2025 | BUY |
Strong Buy
+442.4% avg upside
11 analysts
|
$31.00
415.82% Upside
|
-5.3% |
|
MLSS
Milestone Scientific
|
Nov 20, 2025 | BUY |
Strong Buy
+169.3% avg upside
2 analysts
|
$1.00
169.30% Upside
|
-9.7% |
|
SKIN
Beauty Health
|
Nov 07, 2025 | HOLD |
Hold
+408.7% avg upside
11 analysts
|
— | -54.3% |
|
VNRX
VolitionRX
|
Sep 15, 2025 | HOLD |
Strong Buy
+589.8% avg upside
11 analysts
|
— | -81.9% |
|
RVPH
Reviva Pharmaceuticals Holdings
|
Sep 15, 2025 | BUY |
Strong Buy
+7085.8% avg upside
9 analysts
|
$140.00
22850.85% Upside
|
-91.7% |
|
MOVE
Movano
|
Apr 24, 2025 | BUY |
Strong Buy
+33.2% avg upside
4 analysts
|
$30.00
33.21% Upside
|
+167.2% |
|
MODD
Modular Medical
|
Nov 26, 2024 | BUY |
Strong Buy
+56.6% avg upside
3 analysts
|
$8.00
55.34% Upside
|
-75.9% |
|
RKTO
Rocket One
|
Oct 11, 2024 | BUY |
Strong Buy
+905.3% avg upside
8 analysts
|
$3.00
177.85% Upside
|
· |
|
CDIO
Cardio Diagnostics Holdings
|
Jun 06, 2024 | BUY |
Strong Buy
+152.6% avg upside
2 analysts
|
$2.00
1.09% Upside
|
-76.7% |
|
TNON
Tenon Medical, Inc.
|
Apr 15, 2024 | BUY |
Strong Buy
+2685.7% avg upside
3 analysts
|
$24.00
6757.23% Upside
|
-80.5% |
|
USBC
USBC
|
Apr 08, 2024 | BUY |
Buy
+139.0% avg upside
2 analysts
|
$1.00
138.96% Upside
|
· |
|
BIOLQ
BIOLASE
|
Mar 22, 2024 | BUY |
Strong Buy
+1197999900.0% avg upside
6 analysts
|
$0.40
39999899.94% Upside
|
· |
|
SEELQ
Seelos Therapeutics
|
Sep 21, 2023 | BUY |
Buy
+46385614.3% avg upside
10 analysts
|
$240.00
239999899.98% Upside
|
-99.6% |
|
STAA
Staar Surgical
|
Sep 15, 2023 | HOLD |
Hold
+14.3% avg upside
16 analysts
|
— | -25.3% |
|
IMDX
Insight Molecular Diagnostics
|
Aug 24, 2023 | BUY |
Buy
-0.6% avg upside
10 analysts
|
$5.00
8.10% Downside
|
· |
|
GDTC
CytoMed Therapeutics Limited
|
Jul 21, 2023 | BUY |
Strong Buy
+354.5% avg upside
1 analyst
|
$5.00
354.52% Upside
|
· |
|
HSCS
Heart Test Laboratories, Inc.
|
Mar 23, 2023 | BUY |
Strong Buy
+334.8% avg upside
3 analysts
|
$4.00
117.31% Upside
|
-88.3% |
|
ORGS
Orgenesis
|
Mar 22, 2023 | BUY |
Strong Buy
+1784.4% avg upside
1 analyst
|
$6.00
1784.36% Upside
|
· |
|
CNSP
CNS Pharmaceuticals
|
Jun 29, 2021 | BUY |
Strong Buy
+495.7% avg upside
5 analysts
|
$8.00
70.14% Upside
|
-87.1% |
|
SNOA
Sonoma Pharmaceuticals
|
Jul 20, 2018 | BUY |
Buy
+1755.0% avg upside
4 analysts
|
$27.00
2247.74% Upside
|
-71.5% |
|
HRTX
Heron Therapeutics
|
Apr 05, 2018 | BUY |
Strong Buy
+6439.5% avg upside
21 analysts
|
$42.00
9959.79% Upside
|
-6.5% |
|
AXGN
AxoGen
|
Mar 02, 2018 | BUY |
Strong Buy
-25.8% avg upside
21 analysts
|
$38.00
15.18% Downside
|
-41.5% |
|
MDXG
MiMedx Group
|
Feb 26, 2018 | HOLD |
Strong Buy
+185.0% avg upside
17 analysts
|
— | -58.9% |
|
LCTX
Lineage Therap
|
Feb 02, 2018 | BUY |
Strong Buy
+342.7% avg upside
16 analysts
|
$8.00
561.10% Upside
|
· |
|
IART
Integra Lifesciences
|
Oct 28, 2016 | BUY |
Buy
+137.0% avg upside
21 analysts
|
$92.00
423.26% Upside
|
+13.4% |
|
MDT
Medtronic
|
Nov 21, 2012 | HOLD |
Buy
+23.7% avg upside
38 analysts
|
$46.00
42.10% Downside
|
+36.6% |
|
BSX
Boston Scientific
|
Mar 02, 2012 | BUY |
Strong Buy
+73.0% avg upside
38 analysts
|
— | +22.8% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.